Global Infection Surveillance Solutions Market Trends to Reach Worth USD 1.32 BN by 2026 | CAGR 7.2%

Infection Surveillance Solutions Market (By Product and Services – Software [On-premise, Web-based], Services; By Infection Type – Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Others; By End-use – Long Term Care Facilities, Hospitals, Others) – Global Industry Size, Share, Trends and Forecast 2018 – 2026; Rise in Number of Surgeries, Growing Prevalence of Healthcare Associated Infections (HAIs), Increasing Adoption of Automation and Government Initiatives to Drive The Market Growth

The global infection surveillance solutions market was valued around US$ 305.1 Mn in 2017 and is anticipated to expand at a stable CAGR above 14.0% during the forecast period 2018 to 2026. According to the report titled “Infection Surveillance Solutions Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2018-2026”. Rise in number of surgeries, growing prevalence of healthcare associated infections (HAIs), increasing adoption of automation and government initiatives have increased the growth of the global Infection Surveillance Solutions market. The market in the North America is likely to expand at significant CAGR due to numerous advancements in healthcare infrastructure, rising incidence of HAIs and strong government initiatives in the region.

Download Sample Copy of this Report@ https://www.acumenresearchandconsulting.com/request-sample/936

Increasing healthcare infrastructure development scenario to fuel the growth for software segment

In terms of product and services, the global infection surveillance solutions market is bifurcated into software and services. Software segment accumulated the highest market share in 2017 and anticipated to dominate the market throughout the forecast period. The software segment is further categorized into on-premise and web-based software. The web based software is foreseen to witness the most noteworthy CAGR during the forecast period. The development of the sub-section can be credited to its advantages over on-premise software including accessibility in various designs, fast return investment, and ongoing technological innovations. In addition, medicinal services IT organizations are mainly focusing on innovative data management solutions that make collection of electronic health records (EHR), through their software. Moreover, the services segment is projected to exhibit a higher CAGR during the forecast period due to higher adoption of software packages in healthcare facilities.

On the other hand, by infection type, the infection surveillance solutions market has been segmented into urinary tract infections (UTI), surgical site infections (SSI), blood stream infections (BSI), and others. Tract infections (UTI) segment is likely to maintain its dominance over the forecast period.

Browse Full Report with Table of Content, List of Table and Figures@ https://www.acumenresearchandconsulting.com/infection-surveillance-solutions-market

Increasing occurrences of healthcare associated infections (HAIs) surging the demand for infection surveillance solution

Hospital related diseases in a clinical setting including urinary tract disease, and pneumonia and other infectious diseases are expanding because of contaminated instruments and devices, bed materials and patient garments and others. This has provoked healthcare experts and clinics to adopt infection surveillance system in order to recognize possible healthcare related infections. These systems also help in diagnosing various infections due to non hygienic medical devices and antibiotic resistant organisms (AROs). Infection surveillance solutions include fully automated HAI surveillance, specific data mining software, usage of algorithms with electronic medical records that helps in early identification of certain clinical infections.

Regional Analysis

Geographically, the global infection surveillance solutions market has been divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2017, North America was the topmost revenue generating region owing to the early adoption of advanced clinical products and continuous development of healthcare infrastructure in the region. North America is anticipated to grow at significant CAGR over the forecast period. Rising incidence of HAIs and Strong government initiatives in the U.S. and Canada are fueling the growth of domestic market. Prominent players from the region are making considerable investments in order to introduce advanced infection surveillance solutions. Asia Pacific is also expected to show significant growth rate during the forecast period owing to the rising medical tourism and improving healthcare infrastructure. However, the lack of awareness among people towards automation and availability of advanced systems are some of the challenging factors for infection surveillance solutions market in Asia Pacific.

Becton, Wolters Kluwer N.V, Baxter International Inc., and Gojo Industries are likely to contribute highest market share in the global infection surveillance solutions market.

The company profiling of key players in the global Infection Surveillance Solutions market includes company overview, major business strategies and revenues. The key players of the market are Becton, Premier Inc., Wolters Kluwer N.V, Dickinson and Company, Gojo Industries, Baxter International Inc., RL Solutions, Truven Health Analytics and Premier Inc. Industry participant battle on the basis of price, new innovated product launch, and expanding market presence.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Infection Surveillance Solutions
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Infection Surveillance Solutions Market By Product and Services
1.2.2.1. Global Infection Surveillance Solutions Market Revenue and Growth Rate Comparison By Product and Services (2015-2026)
1.2.2.2. Global Infection Surveillance Solutions Market Revenue Share By Product and Services in 2017
1.2.2.3. Software
1.2.2.4. Services
1.2.2.5. Others
1.2.3. Infection Surveillance Solutions Market By Infection Type
1.2.3.1. Global Infection Surveillance Solutions Market Revenue and Growth Rate Comparison By Infection Type (2015-2026)
1.2.3.2. Surgical Site Infections (SSI)
1.2.3.3. Blood Stream Infections (BSI)
1.2.3.4. Urinary Tract Infections (UTI)
1.2.3.5. Others
1.2.4. Infection Surveillance Solutions Market By End Users
1.2.4.1. Global Infection Surveillance Solutions Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Long Term Care Facilities
1.2.4.3. Hospitals
1.2.4.4. Others (Clinics, and Ambulatory Surgical Centers)
1.2.5. Infection Surveillance Solutions Market by Geography
1.2.5.1. Global Infection Surveillance Solutions Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Infection Surveillance Solutions Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Infection Surveillance Solutions Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Infection Surveillance Solutions Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Infection Surveillance Solutions Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Infection Surveillance Solutions Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Hospitals Production Date of Global Infection Surveillance Solutions Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Infection Surveillance Solutions Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Infection Surveillance Solutions Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Infection Surveillance Solutions Major Manufacturers in 2017

CHAPTER 4. INFECTION SURVEILLANCE SOLUTIONS MARKET BY PRODUCT AND SERVICES

4.1. Global Infection Surveillance Solutions Revenue By Product and Services
4.2. Software
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Services
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Other
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. INFECTION SURVEILLANCE SOLUTIONS MARKET BY INFECTION TYPE

5.1. Global Infection Surveillance Solutions Revenue By Infection Type
5.2. Surgical Site Infections (SSI)
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Blood Stream Infections (BSI)
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Urinary Tract Infections (UTI)
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USERS

6.1. Global Infection Surveillance Solutions Revenue By End Users
6.2. Long Term Care Facilities
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Hospitals
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Others (Clinics, and Ambulatory Surgical Centers)
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 7. NORTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY

7.1. North America Infection Surveillance Solutions Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. North America Infection Surveillance Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Infection Surveillance Solutions Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 8. EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY

8.1. Europe Infection Surveillance Solutions Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Europe Infection Surveillance Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY

9.1. Asia-Pacific Infection Surveillance Solutions Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Asia-Pacific Infection Surveillance Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
9.8.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 10. LATIN AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY

10.1. Latin America Infection Surveillance Solutions Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Latin America Infection Surveillance Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 11. MIDDLE EAST INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY

11.1. Middle East Infection Surveillance Solutions Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Middle East Infection Surveillance Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 12. AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY

12.1. Africa Infection Surveillance Solutions Market Revenue and Growth Rate, 2015 – 2026 ($Million)
12.2. Africa Infection Surveillance Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
12.3.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
12.4.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product and Services, 2015 – 2026 ($Million)
12.5.2. Market Revenue and Forecast By Infection Type, 2015 – 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Becton Dickinson and Company
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Premier Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Wolters Kluwer N.V
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Gojo Industries
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Baxter International Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. RL Solutions
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Truven Health Analytics
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Premier Inc
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Others
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/936

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/936

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157